← Open Payments lookup

TAMI MILLER: Open Payments

NPI 1174164263 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$472 in 23 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $380 · 2025 $472

Food & beverage: $472
CompanyPaymentsAmount
ABBVIE INC.5$102
AstraZeneca Pharmaceuticals LP3$56
Lilly USA, LLC3$52
PFIZER INC.2$45
Novo Nordisk Inc2$39
GlaxoSmithKline, LLC.2$39
Novartis Pharmaceuticals Corporation1$31
Dexcom, Inc.1$25
Xeris Pharmaceuticals, Inc.1$24
Verona Pharma, Inc.1$23

Products named: MOUNJARO, UBRELVY, FARXIGA, TRELEGY ELLIPTA, VRAYLAR, LEQVIO, Dexcom G6 Transmitter, RECORLEV.

Industry payments across ID — which companies pay providers there.